Bonnie J. Addario Lung Cancer Foundation Launches First Ever Simplified Chinese Resources to Help Patients Navigate Care, Diagnosis and Treatment

ALCF releases simplified Chinese version of Patient Handbook for
Asian communities

SAN CARLOS, Calif.–(BUSINESS WIRE)–Today, the Bonnie J. Addario Lung Cancer Foundation (ALCF)
released a simplified Chinese language version of its patient handbook,
“Navigating Lung Cancer, 360 Degrees of Hope,” to provide critical
information and resources for Asian lung cancer patients and caregivers
across the world.

“There is a huge void of resources for Asians with lung cancer,” said
Bonnie J. Addario, 10-year lung cancer survivor and founder of the ALCF.
“Being diagnosed with cancer is scary enough, but not knowing what
resources are available to educate yourself makes good health-care
decision making impossible. By removing this language barrier, we are
helping them to receive the care they need.”

Lung cancer is the number one cause of cancer deaths in Asians, but 40
percent of those diagnosed have never smoked, according to the American
Cancer Society.*

“As the presenting sponsor, Boehringer Ingelheim is proud to support the
ALCF’s pioneering initiative to reach the Asian community with tailored
educational resources,” said Kevin Lokay, vice president and business
unit head of oncology, Boehringer Ingelheim Pharmaceuticals, Inc. “Half
of Asians with lung cancer have a specific kind of cancer mutation,
which may impact their future prognosis and treatment, yet many have
little awareness about lung cancer diagnosis, molecular testing and
treatment options. Through this initiative and several others in the
Asian community, we are working to increase understanding of lung cancer
in Asians so that we can help everyone fight this devastating disease.”

The ALCF’s patient handbook is a first-of-its-kind, comprehensive,
up-to-date patient resource for lung cancer patients and their families.
First released in English in early 2013, the handbook contains the
latest advancements in lung cancer care, including new FDA approved
drugs, molecular testing, immunotherapy and a special clinical trials
report. The resource is now available in Spanish and simplified Chinese,
online and in print.

“Translating the manual into simplified Chinese is a great boon to
Chinese lung cancer patients,” said David Jablons, M.D., FACS, Professor
and Chief of the Section of General Thoracic Surgery at UCSF, and
Program Leader of Thoracic Oncology. “China is the epicenter of a
mushrooming lung cancer crisis and remains the dominant health care
problem in China. The manual will be a welcomed adjunct to the
soon-to-be millions of lung cancer patients in China and yet again
confirms the ALCF’s global commitment to patient advocacy. An informed
patient is an empowered patient. This manual will undoubtedly be an
important tool for Chinese patients, families and physicians alike all
united by the great struggle against lung cancer.”

To learn more about ALCF, visit
and follow its activities on Twitter
and Facebook.

*American Cancer Society. Cancer Facts and Figures 2014. Atlanta:
American Cancer Society; 2014 Toh C K, Gao F, Lim W T. et al
Never-smokers with lung cancer; epidemiological evidence of a distinct
disease entity. J Clin Oncol 2006. 242245-2251,2251

About the Bonnie J. Addario Lung Cancer Foundation

The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the
largest philanthropies (patient-founded, patient-focused, and
patient-driven) devoted exclusively to eradicating lung cancer through
research, early detection, education, and treatment. The Foundation’s
goal is to work with a diverse group of physicians, organizations,
industry partners, individuals, patients, survivors, and their families
to identify solutions and make timely and meaningful change and turn
lung cancer into a chronically managed disease by 2023. The ALCF was
established on March 1, 2006 as a 501c(3) non-profit organization and
has raised more than $20 million for lung cancer research and related


Perry Communications Group
Julia Spiess Lewis, 916-658-0144